ReviewFrontiers in chemistry2023

Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment.

Mahdie Rahban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.